Expected Revenue Growth:
The global protein binding assays market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at CAGR of 10.7%. The increasing use of protein binding assays in pre-clinical research for studying the distribution properties of the drug, and the growing number of drug discovery activities, the minimizing drug discovery and development costs, and the increase in pharmaceutical R&D expenditure is driving the growth of this market.
Based on technology, equilibrium dialysis segment is expected to grow at the highest CAGR in the market during the forecast period
On the basis of technology, the global protein binding assays market is divided into equilibrium dialysis, ultrafiltration, ultracentrifugation, and other technologies. In 2018, the equilibrium dialysis segment is expected to grow at the highest CAGR in the protein binding assays market. The growth can be attributed to the technique’s physical simplicity, low cost, and high accuracy. It is also considered as a gold standard technique for protein binding studies.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=44025612
Based on end user, Contract Research Organizations (CROs) segment is expected to grow at the highest CAGR in the market during the forecast period
On the basis of end user, the global protein binding assays market is divided into pharmaceutical and biotechnology companies, CROs, and other end users. In 2018, the CROs segment is expected to grow at the highest CAGR in the global protein binding assays market. This high growth can be attributed to the increase increased protein binding studies for drug discovery & development by pharmaceuticals and the growing focus of biotechnology companies on developing biologics.
Objectives of the Study:
# To define, describe, and forecast the protein binding assay market on the basis of technology, end user, and regions.
# To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).
# To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.
# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
# To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).
# To profile the key players in the market and comprehensively analyze their market positions and core competencies.
# To track and analyze competitive developments such as partnerships, agreements, and joint ventures; mergers and acquisitions; product development; and research and development activities in the protein binding assay market.
Asia Pacific is expected to grow at the highest CAGR during the forecast period
The APAC market is projected to register the highest growth rate during the forecast period primarily due to factors such as, growth of clinical trial activities in several APAC countries. As a result of this, the pharmaceutical and biopharmaceutical companies are outsourcing their drug discovery and development activities to APAC-based CROs. This is one of the major factors driving the growth of the protein binding assay market in the Asia Pacific.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=44025612
Target Audience:
# Government and academic institutes
# Protein binding assay providers
# R&D departments
# Contract research organizations
# Pharmaceutical & biotechnology companies
# Consulting firms
# Government associations
Market Players
The key players in the global protein binding assays market are HTDialysis (US), Thermo Fisher Scientific (US), Merck (Germany), and Sovicell (Germany).
Wednesday, March 31, 2021
Protein Binding Assays Market worth $425.7 million in 2023
Peptide Synthesis Market - Global Key Players & Their Dominance in Global Industry
The peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5% during the forecast period.
The global peptide synthesis market is a fragmented market. GenScript Biotech Corporation (China), Merck KGAA (Germany), AAPPTec (US), Bachem (Switzerland), and Biotage (Sweden) dominated the global peptide synthesis market in 2017.
GenScript Biotech Corporation
GenScript accounted for the largest share of the market in 2017. The company has a broad product/services portfolio in peptide synthesis market and focuses on research and development activities to enhance its offerings. For Instance, in 2016 the company’s research and development expenses were approximately USD 9.5 million, 8.3% of the total revenue. Also during the same year the revenue generated from the life sciences research services segment (that provides peptide synthesis services and products) was approximately USD 91.2 million, representing an increase of 18.6% as compared to approximately USD 76.9 million for 2015.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365
Merck KGAA
Merck held the second position in the peptide synthesis market in 2017. The company offers a broad product portfolio of peptide synthesis reagents and custom peptide synthesis services in the market. To leverage growth opportunities in the peptide synthesis market, Merck focuses on adopting organic as well as inorganic growth strategies. For instance, in 2017, the company opened a new Life Science Center in Burlington, Massachusetts (US). The new center serves as a regional hub for scientific advancement and customer collaboration. Also in 2017, the company acquired Grzybowski Scientific Inventions (GSI). This acquisition helped the company to expand its chemical synthesis offering.
Bachem holdings
Bachem is an important player in the peptide synthesis market in 2017. The company offers catalog products that include amino acids, resins, linkers, & reagents. It also offers custom synthesis services in the market. The company aims on broadening its geographic reach by investing in strategic acquisitions, agreements, and collaborations. For instance in 2017, the company has renewed its supply agreement with AstraZeneca for the peptide active substance Goserelin. Also, in 2017 the Bachem Group entered into the collaboration with DOTTIKON ES to bring innovative, new amino acid derivatives for peptide synthesis in the market.
Increasing use of peptides in pharmaceutical drugs drives the global peptide synthesis market
Peptides are highly active and highly specific drug substances. Due to the diversity of their biological functions, they are used in an extensive range of therapeutic areas. Also, they are increasingly entering drug development pathways as potential active pharmaceutical ingredients due to their large chemical space, high biological activity, high specificity, relative ease of synthesis, ready availability, and low toxicity.
Oncology, diabetes, and obesity are three prominent therapeutic areas in which peptides generate billions of dollars in revenues. As a drug modality, peptides and peptidomimetics occupy the interface between small molecules and larger biological drugs with the potential to have the specificity of antibodies and the bioavailability of small molecules. Moreover, peptides provide researchers with viable options for discovery, optimization, and manufacture, as they can be synthesized chemically or expressed by recombinant systems. As a result of these advantages, pharmaceutical companies are increasingly focusing on the development of peptide-based drugs.
Pharmaceutical & biotechnological companies are expected to dominate the peptide synthesis market in 2017
Based on end users, the peptide synthesis market is segmented into pharmaceutical & biotechnological companies, contract development and manufacturing organizations, and academic and research institutes. In 2017, pharmaceutical & biotechnological companies accounted for the largest market share due to increasing number of research projects in genomics, molecular biology, and related areas; growing application areas of peptides in drug discovery, therapeutics, and research; and substantial R&D investments.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=158927365
APAC is expected to grow at the highest CAGR during the forecast period.
Global peptide synthesis market has been studied for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. APAC is expected to grow at the highest CAGR in the peptide synthesis market, primarily due to the increasing investments by pharmaceutical and biotechnology companies and rising R&D activities in the region.
Tuesday, March 30, 2021
Pharmaceutical Drug Delivery Market worth $2,015.3 billion by 2025
Market Size Estimation:
The total market size for pharmaceutical drug delivery technology market was arrived at after data triangulation from two different approaches, as mentioned below:
# Approach to calculate the revenue of different players in the pharmaceutical drug delivery technology market
# Approach to derive the market size and estimate market growth
Data Triangulation:
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Download PDF Brochure@
Report Objectives:
# To define, describe, and forecast the global pharmaceutical drug delivery market on the basis of route of administration, application, facility of use, and region.
# To provide detailed information about the factors influencing market growth (drivers, restraints, and opportunities).
# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market.
# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
# To forecast the size of market segments in North America, Europe, Asia Pacific, and the Rest of the World.
# To profile key players and comprehensively analyze their product portfolios, market rankings, and core competencies.
# To track and analyze competitive developments, such as acquisitions, collaboration, product approvals, expansions, and agreements in the global pharmaceutical drug delivery market.
Expected Revenue Growth:
This market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period.
Growth Boosting Factors:
The factors supporting market growth include the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements & new product launches.
North America was the largest regional market for pharmaceutical drug delivery in 2019
The global pharmaceutical drug delivery market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the market. The large share of the North American market can be attributed to factors such as growth in biologics in the pharmaceuticals market; the rising prevalence of chronic diseases increasing patient compliance to innovative drug delivery technologies; and the presence of a large number of prominent players in this region.
Request Sample Pages@
Key Players:
The global pharmaceutical drug delivery market is highly competitive owing to the presence of several large and small players. Johnson & Johnson, Inc. (US), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (US), Bayer AG (Germany), Pfizer, Inc. (US), Novartis AG (Switzerland), 3M Company (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc, (UK), Sanofi (France), and Antares Pharma, Inc. (US) are some of the leading players operating in the pharmaceutical drug delivery market.
Air Quality Monitoring System Market - Technological Advancements in the Field of Air Pollution Monitoring
Research Methodologies Followed:
Secondary Research:
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Businessweek, and Factiva) were referred to identify and collect information for this study.
Primary Research:
The market comprises several stakeholders, such as demand-side (research laboratories, pharmaceutical & biotechnology companies, oil and gas companies, pharmaceutical companies, government organizations, and residential users) and the supply side (product manufacturers, contract manufacturers, and product distributors). Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183784537
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the market. These methods were also used extensively to determine the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# Product mapping of various manufacturers for each type of air quality monitoring products at the regional and country-level
# Relative adoption pattern of each air quality monitoring product among key end-users at regional and country-level
# Detailed primary research to gather quantitative information related to segments and subsegments at the regional and/or country-level
# Detailed secondary research to gauge prevailing market trends at the regional and/or country-level
Data Triangulation:
After arriving at the overall market size-using the market size estimation processes as explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the air quality monitoring systems market.
Expected Growth in Revenue:
The global air quality monitoring system market (AQMS) is expected to reach USD 6.0 billion by 2025 from USD 4.3 billion in 2019, at a CAGR of 5.6%.
Major Growth Boosting Factors:
The major factors driving the growth of the air quality monitoring system market include the supportive government regulations for effective air pollution monitoring and control, ongoing initiatives towards the development of environment-friendly industries, increasing public-private funding for effective air pollution monitoring, rising levels of air pollution, and increasing public awareness related to the environmental and healthcare implications of air pollution.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=183784537
End Users
Government agencies and academic institutes held the largest share of the AQMS market in 2019
Based on end-user, the air quality monitoring system market is segmented into government agencies and academic institutes, commercial and residential users, petrochemical industry, power generation plants, pharmaceutical industry, smart city authority, and other end users. The government agencies and academic institutes segment accounted for the largest share in 2018. The large share of this segment can be attributed to the presence of stringent environmental regulations, rising government investments for effective AQM, and increased installation of AQM stations worldwide.
Geographical Growth Scenario:
North America to dominate the AQMS market during the forecast period
Geographically, the AQMS market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America held the largest share of the market in 2019. Factors such as easy accessibility and fast adoption of advanced technologies among key stakeholders and the presence of stringent government regulations for effective pollution monitoring and control are contributing to the large share of the North American region.
Global Players:
The major players operating in the AQMS market include Thermo Fisher Scientific (US), Emerson Electric (US), General Electric (US), Siemens AG (Germany), Teledyne Technologies (US), PerkinElmer, Inc. (US), Agilent Technologies, Inc. (US), Spectris plc (UK), 3M Company (US), Honeywell International Inc (US), HORIBA, Ltd. (Japan), Merck KGaA (Germany), TSI Incorporated (US), Tisch Environmental (US), and Testo (Germany), among others.
Read Detailed Report@
https://www.marketsandmarkets.com/Market-Reports/air-quality-monitoring-equipment-market-183784537.html
Friday, March 26, 2021
Protein Assays Market worth 2.41 Billion USD by 2022
This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the protein assays market, along with revenue estimates & forecasts and market share analysis.
The global protein assays market is expected to reach USD 2.41 Billion by 2022 from USD 1.42 Billion in 2017, at a CAGR of 11.1% from 2017 to 2022. The increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics research are the major factors driving the growth of this market. In this report, the global protein assays market is segmented based on type, product, technology, application, end user, and region.
Global Industry Segmentation:
Based on type, the protein assays market is segmented into dye-binding assays, copper-ion-based assays, test strip-based assays, and other protein assays. On the basis of product, the protein assays market is segmented into reagents, kits, and instruments & accessories. In 2017, the reagents segment is expected to account for the largest share of the market. This growth can be attributed to the quick and ready-to-use modifications and the requirement of repeat purchase of reagents.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93720547
On the basis of technology, the protein assays market is segmented into absorbance-based protein assays, colorimetric protein assays, and fluorescence-based protein assays. Based on application, the protein assays market is segmented into disease diagnosis, drug discovery & development, and other applications. The drug discovery & development segment is expected to account for the largest market share in 2017. The increase in the R&D expenditure in the life science industry is a key market driver for this segment.
Based on end user, the protein assays market is segmented into pharmaceutical & biotechnology companies, clinical laboratories, hospitals, academic research institutes, and other end users. In 2017, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. This growth can be attributed to the increasing drug development in the life science industry.
On the basis of region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The growth in this region is primarily driven by the increasing pharmaceutical and biotechnology R&D expenditure and availability of government funding for life sciences research.
Key Leaders:
Some of the major players operating in the protein assays market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=93720547
European Medical Equipment Maintenance Market - Emerging Trends to Boost Global Revenue
The European medical equipment maintenance market is expected to reach USD 8.93 Billion by 2022 from USD 6.29 in 2016, at a CAGR of 6.1% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.
Global Growth Boosting Factors:
The growth of the market is attributed to rising focus on preventive maintenance. Preventive maintenance is gaining prominence as planned inspections and medical device maintenance help avoid adverse incidents and medical-device related accidents. Regular maintenance services provided by OEMs, ISOs, or in-house service technicians ensure safe, efficient, and long-lasting use of medical devices. The growing focus on implementing preventive maintenance strategies among healthcare organizations is expected to offer growth opportunities for service providers in the coming years.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243039217
Multi-year maintenance contract to dominate the market in 2017
Based on the type of contract, the European medical equipment market is segmented into multi-year maintenance contracts, and annual maintenance contracts. Among these, multi-year maintenance segment is expected to account for the largest share of the European medical equipment maintenance market. Hospitals with large budgets prefer long-term contracts to match the lifecycle of medical equipment and to avoid renegotiating of service contracts. Moreover, service providers are likely to provide some discount on the final amount for multiple-year contracts thus; multi-year contracts can offer potential cost benefits to providers.
On the basis of end user, private-sector organizations are to grow at the highest CAGR within the forecast period
By end user, the European medical equipment maintenance market is segmented into public sector organizations and private-sector organizations. In 2017, private-sector organizations are expected to register the highest CAGR during the forecast period. The increasing number of public- private partnerships is expected to boost the demand for medical equipment maintenance services in Europe.
Germany to dominate the market followed by Italy
By region, the European medical equipment maintenance market is segmented into Germany, Italy, UK, France, Spain, and RoE. In 2017, Germany accounted for the largest share of the market; this regional segment is also expected to grow at highest CAGR during the forecast period, followed by Italy. The high growth of the German market is attributed to the factors such as the significant presence of OEMs, growing medical technology market, well-established healthcare infrastructure and large installation base of medical equipment. Italy is the second largest growing market, factors such as focus on value-based healthcare system, and strategic expansion of market players, are expected to fuel the market growth in this country.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=243039217
Key Players:
The medical equipment maintenance market is highly competitive with the presence of both OEMs and ISOs. GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Toshiba Medical Systems Europe (Germany), and Drägerwerk AG & Co. KGaA (Germany) are some of the leading OEMs; whereas, TBS Group S.p.A. (Italy), Alliance Medical Group (U.K.), Pantheon Group (Italy), Technologie Sanitarie S.p.A. (Italy), Avensys UK Ltd. (U.K.), and Grupo Empresarial Electromédico (Spain) are some of the leading ISOs operating in the European medical equipment maintenance market.
Thursday, March 25, 2021
Topical Drug Delivery Market worth $129.8 billion by 2025
Research Methodologies Followed for This Study:
Secondary Research:
This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global topical drug delivery market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research:
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, manufacturing managers, and related key executives from various key companies and organizations operating in the global topical drug delivery market. The primary sources from the demand side include purchase and sales managers, research organizations, and pharmaceutical and biotechnology companies.
Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and market dynamics.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124871717
Expected Revenue Growth:
The global market is projected to reach USD 129.8 billion by 2025 from USD 95.2 billion in 2020, at a CAGR of 6.4% during the forecast period. The growth of this market is majorly driven by the high prevalence of skin and soft tissue infections, the increasing prevalence of eye diseases, and burns. However, the presence of alternative drug delivery modes such as oral and injectable routes is expected to restrain the growth of this market during the forecast period.
Effects of COVID19 on Global Industry:
Coronavirus has spread across 215 countries and territories and affected more than 24.6 million people, with close to 835,000 deaths as of August 2020. Due to the COVID-19 outbreak, we are estimating that the share of the nasal drug delivery segment has increased, and this segment is anticipated to grow significantly during the forecast period. COVID-19 has given momentum to various drug delivery technologies in the market. As a result, this market is expected to witness significant growth from 2020 to 2021.
The semi-solid formulations segment is expected to grow at the highest CAGR during the forecast period
Based on the product, the topical drug delivery market is segmented into semi-solid formulations, liquid formulations, solid formulations, and transdermal products. The semi-solid formulations segment is projected to witness the highest growth in the topical drug delivery market during the forecast periods (2020-2025). Growth in this segment is driven mostly by the easy application of semi-solid formulations, and their ability to deliver a wide variety of drug molecules.
North America is expected to hold the largest share for players operating in the topical drug delivery market
North America accounted for the largest share of the topical drug delivery market in 2019. Factors such as presence of a highly developed healthcare system and a large number of topical drug-manufacturing companies in the country are among the few factors expected to contribute to the growth of this market. Furthermore, the growing geriatric population in the US, high disposable incomes, increasing preference for pain-free drug delivery solutions, and the availability of advanced and effective technology are driving market growth in North America.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=124871717
Global Key Players:
The prominent players in this market are Johnson & Johnson (US), Nestle SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), and Bayer AG (Germany).
Key Players in the Hospital Lighting Market - Different Growth Strategies Adopted
Global Key Players:
The hospital lighting market is consolidated in nature due to the presence of a few large players. The prominent players in the market include are General Electric Company (U.S.), Acuity Brands Lighting Inc. (U.S.), Cree Inc. (U.S.), Eaton Corporation PLC (Ireland), Hubbell Incorporated (U.S.), Koninklijke Philips N.V. (Netherlands), and Zumtobel Group AG (Austria). Other players in this market include Herbert Waldmann GmbH & Co. KG (Germany), KLS Martin Group (Germany), and Trilux Lighting Ltd (U.K.).
Koninklijke Philips N.V. (Netherlands) is the largest player in the global hospital lighting market. The company offers a wide range of products for hospital lighting. The company, with its strong product portfolio for hospital lighting has established itself as one of the leading players in this market. The company focuses on product launches to strengthen its position in the market. For instance, in February 2017, Philips Lighting launched the Philips T5 LED tube. The T5 LED tube offers high light output and quality. In January 2017, Philips Lighting launched the Philips VL6000 Beam Luminaire. Philips VL6000 Beam offers a super bright output that exceeds 55,000 lumens. Such product launches enabled the company to maintain its dominance in this market.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=207496480
General Electric Company (U.S.) is the second-largest player in the hospital lighting market. The company adopted product launches as its key strategy to strengthen its position in the market. For instance, in June 2015, GE launched the Bright Stik LED which is considered the replacement for CFL. GE is driving the adoption of LEDs with the introduction of Bright Stik.
Eaton Corporation PLC (Ireland) is the third-largest player in the global hospital lighting market. The company offers a wide range of lighting products used in various healthcare applications. The company focused on growing and improving the profitability of its businesses and implemented a strategy to launch hospital lighting specific products. For instance, in August 2016, Eaton Corporation PLC launched Dim-to-Warm LED technology. LED products are offered in four-color temperatures including 2700K, 3000K, 3500K, and 4000K to satisfy the different needs of dwellings, hospitality, retail, office, and institutional spaces.
The key strategies followed by most companies in the hospital lighting market are product launches. The key players such as Acuity Brands Lighting Inc. (U.S.), Eaton Corporation PLC (Ireland), and Koninklijke Philips N.V. (Netherlands) are the leading manufacturing companies that adopted this strategy to expand their existing product portfolios and enhance their presence in the market.
Expected Growth in Revenue:
The hospital lighting market is projected to reach USD 7.03 Billion by 2021 from USD 5.19 Billion in 2016, at a CAGR of 6.2% from 2016 to 2021. The major factors contributing to the growth of the global hospital lighting market include the increase in adoption of LED technology, increasing size of hospitals in Europe and North America and technological enhancement will offer new opportunities during the forecast period.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=207496480
Global Geographical Growth Scenario:
On the basis of geography, North America dominates the global hospital lighting market. Growth in the North American segment is primarily driven by the technological advancements, government initiatives. For example, the development of Indigo-Clean a product by Kenall Manufacturing launched in 2015, using continuous environmental disinfection technology. Indigo-Clean features technology that continuously disinfects the environment. Such a technological advancement will drive the demand for lights in hospitals.
Wednesday, March 24, 2021
Increasing Popularity of CAD/CAM Technology - Major Growth Booster for Dental Lab Market
Research Methodology Followed for This Study:
Top-down and bottom-up approaches were used to validate the size of the global dental laboratory market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives.
The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources we referred to are the Canadian Dental Association, American Dental Association, British Dental Association, World Health Organization, Indian Dental Association, and Japan Dental Association.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223694318
Target Audience:
# Dental product manufacturers & distributors
# Dental equipment manufacturers & distributors
# Dental laboratories
# Government associations and dental practitioners
# Market research and consulting firms
# Venture capitalists and investors
Europe dominated the market in 2016
Europe accounted for the largest share of the dental laboratories devices market in 2016, followed by North America. The rising geriatric population, increasing dental tourism, growth in the number of dental laboratories, growing government expenditure on oral healthcare across Europe, and presence of higher reimbursement rates for dental procedures in Europe as compared to other regions are the key factors driving the growth of the dental laboratories market in Europe.
Objectives of the Study:
# To define, describe, and forecast the global dental laboratories devices market by material, equipment, prosthetic type, and region.
# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
# To forecast the size of the dental laboratory market, in five main regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa
# To profile key players in the global dental laboratory market and comprehensively analyze their core competencies and market shares
# To track and analyze competitive developments such as research and development activities; joint ventures, alliances, mergers and acquisitions; new product/technology developments; and agreements, partnerships, and other developments of key players in the market
Global Leaders:
The major players in the dental laboratories market are DENTSPLY SIRONA Inc. (US), Danaher Corporation (US), 3M Company (US), Ivoclar Vivadent AG (Liechtenstein), GC Corporation (Japan), Planmeca Oy (Finland), VITA Zahnfabrik H. Rauter GmbH & Co. KG (Germany), Zimmer Biomet Holdings, Inc. (US), Mitsui Chemicals, Inc. (Japan), Septodont Holding (France), and Shofu Inc. (Japan).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=223694318
Expected Revenue Growth:
The dental lab market is expected to reach USD 43.08 Billion by 2022 from an estimated USD 32.56 Billion in 2017, at a CAGR of 5.8% during the forecast period.
Major Growth Boosting Factors:
The rapid growth in the geriatric population and the associated increase in the prevalence of edentulism, growing dental tourism in emerging markets, rising incidence of dental caries and other periodontal diseases, and the increased outsourcing of certain manufacturing functions to dental laboratories.
Vascular Access Device Market - Major Growth Boosting Factors & Future Forecasts
Objectives of the Study:
# To define, describe, and forecast the vascular access devices market by type, application, end user, and region
# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
# To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
# To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
# To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
# To profile the key players and analyze their market shares and core competencies
# To track and analyze competitive developments such as product launches, approval, agreements, collaborations, and acquisitions in the global market
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122149686
The central vascular access device segment to hold the largest share of the market in 2017
By type, the market segment is segmented into central vascular access devices, peripheral vascular access devices, and accessories. Central vascular access devices are expected to account for the largest share of the market in 2017. The growth of this segment is attributed to the wide usage of central vascular access devices in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.
Target Audience:
# Vascular access device manufacturers and distributors
# Interventional cardiology vascular device manufacturers
# Research and consulting firms
# Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
# Research institutes
# Vendors/service providers
# Niche companies manufacturing novel vascular access devices
# Research and consulting firms
By end user, hospitals are expected to hold largest market share in 2017
Based on the end users, the market is segmented into hospitals, clinics and ambulatory care centers, and other end users. In 2017, the hospital segment is expected to dominate this market. The large share of this segment can be attributed to the fact that a majority of vascular procedures are performed in hospital settings.
Research Methodology Followed:
Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of other dependent submarkets. Various secondary sources such as associations World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Association of Percutaneous Cardiovascular Interventions (EAPCI) directories, Society for Cardiac Angiography and Interventions (SCAI), industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study ofthis market. Primary sources such as experts from both supply and demand sides have been interviewed to obtainand validateinformation as well as to assess dynamics of this market.
By application, the drug administration segment is expected to dominate the market in 2017
Based on application, the market is broadly classified into drug administration, fluids and nutrition administration, blood transfusion, and diagnostics and testing. The drug administration segment is estimated to account for the largest share of the market in 2017, the growth of drug administration segment is attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=122149686
North America to hold the largest share of the market in 2017
North American segment is expected to account the largest share of the market in 2017. Market growth in this region is primarily driven by factors such as the high prevalence of cardiovascular diseases; increasing number of research studies and clinical trials for vascular access devices in the U.S.; and the increase in chemotherapy procedures. Moreover, the increasing number of cardiac arrest cases, an increase in the number of minimally invasive procedures and the increase in cancer incidences in Canada are other factors driving the growth of this market in this region.
Global Key Players:
Some prominent players in the market include Becton Dickinson and Company (U.S), C.R.Bard, Inc. (U.S.), and Smiths Medical, Inc. (U.K.). Other players include Teleflex Incorporated (U.S.) B Braun Melsungen Ag (Germany), AngioDynamics (U.S.), Terumo Corporation (Japan), Nipro Medical Corporation, Edwards Lifesciences Corporation (U.S.), Ameco Medical (Egypt), Romsons Scientific & Surgical Pvt. Ltd (India), and Prodimed (France).
Tuesday, March 23, 2021
Laparoscopic Repair Surgery Market - Major Revenue Surge is Expected in Near Future
The laparoscopic and open hernia mesh repair surgery market is projected to reach USD 3.53 Billion by 2022 from USD 3.18 Billion in 2017, at a CAGR of 2.1% during the forecast period.
The rising adoption of mesh in hernia repair surgeries, rising geriatric population, new product developments, and favorable reimbursement scenario in developed countries are the major factors driving the growth of this market.
The report analyzes and studies the patient population affected with hernia in the US, Canada, Germany, France, the UK, Italy, Spain, Japan, China, and India. Along with patient population, the report studies the adoption of open and laparoscopic hernia repair surgeries and the adoption of tack and glue applicators for mesh fixation.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260433127
Based on the type of hernia repair surgery, open hernia repair surgery accounted for the largest market share in 2017. Open hernia repair does not require any advanced equipment and takes 25% lesser time than laparoscopy. This makes open hernia repair more cost effective. Moreover, this type of surgery is preferred for hernias that have been present for a long period of time.
Based on the type of mesh fixator, glue applicators are expected to register the highest growth rate in the forecast period. The cost effectiveness, reduction in surgery time, and lower pain associated with glue fixation are driving the adoption of glue in hernia mesh fixation.
The US accounted for the largest share of the hernia mesh repair surgery market in 2017. The large share of the US is attributed to the large patient population, increasing adoption of technologically advanced products, and presence of a well-established medical reimbursement policy in the country.
Global Key Players:
The major players in the hernia mesh repair surgery market profiled in this report are Medtronic (Ireland), Johnson & Johnson (US), B. Braun (Germany), C. R. Bard (US), and W.L. Gore (US).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=260433127
Peptide Synthesis Market - Emerging Trends to Boost the Global Industry Revenue
Increasing use of peptides in pharmaceutical drugs drives the global peptide synthesis market
Peptides are highly active and highly specific drug substances. Due to the diversity of their biological functions, they are used in an extensive range of therapeutic areas. Also, they are increasingly entering drug development pathways as potential active pharmaceutical ingredients due to their large chemical space, high biological activity, high specificity, relative ease of synthesis, ready availability, and low toxicity.
Oncology, diabetes, and obesity are three prominent therapeutic areas in which peptides generate billions of dollars in revenues. As a drug modality, peptides and peptidomimetics occupy the interface between small molecules and larger biological drugs with the potential to have the specificity of antibodies and the bioavailability of small molecules. Moreover, peptides provide researchers with viable options for discovery, optimization, and manufacture, as they can be synthesized chemically or expressed by recombinant systems. As a result of these advantages, pharmaceutical companies are increasingly focusing on the development of peptide-based drugs.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158927365
Major Objectives of the Study:
# To define, describe, and forecast the peptide synthesis market on the basis of product, technology, end user, and region.
# To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges).
# To strategically analyze micromarkets with respect to the individual growth trends, prospects, and contributions to the overall market.
# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
# To forecast the size of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
# To profile key players and comprehensively analyze their market shares and core competencies in the global market.
# To track and analyze competitive developments such as partnerships, agreements, & collaborations; mergers & acquisitions; product developments; and geographical expansions in the global market.
Pharmaceutical & biotechnological companies are expected to dominate the peptide synthesis market in 2017
Based on end users, the peptide synthesis market is segmented into pharmaceutical & biotechnological companies, contract development and manufacturing organizations, and academic and research institutes. In 2017, pharmaceutical & biotechnological companies accounted for the largest market share due to increasing number of research projects in genomics, molecular biology, and related areas; growing application areas of peptides in drug discovery, therapeutics, and research; and substantial R&D investments.
Target Audience:
# Biotechnology & pharmaceutical companies
# Market research and consulting firms
# Venture capitalists and investors
# Research & development companies
# Contract research organizations (CROs)
# Academic research institutes
# Government institutes
APAC is expected to grow at the highest CAGR during the forecast period.
Global peptide synthesis market has been studied for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. APAC is expected to grow at the highest CAGR in the peptide synthesis market, primarily due to the increasing investments by pharmaceutical and biotechnology companies and rising R&D activities in the region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=158927365
Expected Revenue Growth:
The overall peptide synthesis market was valued at USD 292.4 million in 2017 and is projected to reach USD 426.4 million by 2023, at a CAGR of 6.5% during the forecast period. Market growth can be attributed to increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced peptide synthesizers. The base year considered for the study is 2017, and the forecast has been provided for the period between 2018 and 2023.
Global Key Players:
The prominent players in the peptide synthesis market are GenScript Biotech Corporation (China), AAPPTec (US), Bachem (Switzerland), AnaSpec (US), Biotage (Sweden), CEM Corporation (US), Gyros Protein Technologies (Sweden), Advanced ChemTech (US), Merck KGaA (Germany) and New England Peptide, Inc (US).
Different Growth Strategies Adopted by Them:
Product launches and agreements, partnerships and collaborations were the major strategies adopted by these payers to maintain their positions in the peptide synthesis market.
Monday, March 22, 2021
Fill Finish Manufacturing Market worth $12.1 billion by 2025
The global fill finish manufacturing market size is projected to reach USD 12.1 billion by 2025 from USD 7.5 billion in 2020, at a CAGR of 10.0% during the forecast period. The major factors driving the growth of this market include rising technological advancements in fill-finish manufacturing processes, the growth of the biopharmaceutical industry, and the rising adoption of prefilled syringes for parenteral dosage forms.
Overview of This Research:
The study involved two major activities in estimating the current market size of the fill-finish manufacturing market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609
The consumables segment accounted for the largest share of the fill-finish manufacturing market, by product, in 2019
Based on products, the fill finish manufacturing industry is segmented broadly into consumables and instruments. The consumables segment accounted for the largest market share in 2019. The large share and high growth of this segment can primarily be attributed to the rising demand for prefilled syringes, wide applications of vials in lyophilization, and the growing use of disposable packaging for biologics.
The integrated systems segment accounted for the largest share of instruments, by systems, in the fill finish manufacturing market in 2019
Based on systems, the instrument segment is divided into integrated systems and standalone systems. The integrated systems segment dominated the market in 2019. Owing to its benefits over standalone systems, such as increase productivity and high-speed lines performing multiple operations on the same unit, are driving the adoption of integrated systems in fill-finish operations of drugs.
Europe accounted for the largest share of the fill finish manufacturing market in 2019
The large share of Europe in this market is attributed to factors such as growing focus on the development of biosimilar due to the patent expiry of key biologics products. In addition, well-established reimbursement systems for drugs have further enhanced the demand for biologics among patients by making them affordable to consume, and to fulfill this, biopharmaceutical companies have increased their production volumes and expand production capacities.
Global Leaders:
The major companies in the fill finish manufacturing market are Becton, Dickson and Company (US), Syntegon Technology GmbH (Germany), I.M.A. (Industria Macchine Automatiche) S.p.A. (Italy), Stevanato Group (Italy), West Pharmaceutical Services, Inc. (US), OPTIMA Packaging Group GmbH (Germany), Bausch+Strobel (Germany), Groninger & Co. GmbH (Germany), and Gerresheimer AG (Germany).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=6249609
Sleep Apnea Devices Market - Emerging Trends & Global Future Forecasts
Overview of This Study:
The study involved four major activities in estimating the current market size for sleep apnea devices. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and sub-segments
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the sleep apnea devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and markets have been identified through extensive secondary research.
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719
Revenue Growth Expectations:
The global sleep apnea devices market is expected to reach USD 7.5 billion by 2024 from USD 4.5 billion in 2019 at a CAGR of 10.7%.
Major Growth Boosters:
The major factors driving the growth of the sleep apnea devices market are primarily a large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, considerable venture capital funding, and an increasing number of companies venturing into sleep apnea and oral appliances markets.
The therapeutic devices segment accounted for the largest market share during the forecast period.
On the basis of type, the sleep apnea devices market has been segmented into therapeutic devices and diagnostic devices. The therapeutic devices segment accounted for the largest share of the market during the forecast period and is projected to register the highest CAGR during the forecast period. The key factors contributing to this growth are the increasing number of undiagnosed sleep apnea patients across the globe and the improving reimbursement scenario for these devices. Moreover, there is also an inclination towards adoption of oral appliances considering the high rate of non-compliance with PAP devices.
Home care settings/individuals projected to grow at the highest CAGR in the global sleep apnea devices market during the forecast period
On the basis of end user, the sleep apnea devices market has been segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of the market in 2018, while home care settings/individuals end-user segment is projected to grow at the highest CAGR during the forecast period. This high growth is likely driven by factors such as the rising preference for home sleep testing by both patients and private insurance companies, along with the favorable reimbursement scenario for home sleep testing.
North America is expected to dominate the sleep apnea devices market during the forecast period
On the basis of region, North America accounted for the largest share of the global sleep apnea devices market in 2018, whereas, the Asia Pacific region registered the highest CAGR during the forecast period. North American accounted for the largest share owing to factors like an increase in the number of patients diagnosed with sleep apnea in the region, growth in awareness initiatives being taken by various government and non-government organizations, availability of adequate funding for research and development, and substantial growth in the usage of oral appliances in the region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=719
Global Key Players:
Major players operating in the sleep apnea devices market include ResMed (US), Koninklijke Philips (Netherlands), Fisher & Paykel Healthcare (New Zealand), SomnoMed (US), Oventus Medical (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Drive DeVilbiss Healthcare (US), BMC Medical (China), Braebon Medical (Canada), and Panthera Dental (Canada).
Friday, March 19, 2021
Liquid Handling System Market worth $3.74 Billion by 2022
Expected Revenue Growth:
The liquid handling systems market is expected to reach USD 3.74 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 7.2%.
Major Growth Boosting Factors:
Factors driving the growth of this market include the global growth in the biotechnology and pharmaceutical industries, rising demand for high-throughput screening (HTS), increasing focus on data precision and accuracy, and technological innovations to develop novel liquid handling systems.
Target Audience for this Report:
# Genomics and proteomics associations
# Drug discovery and development research centers
# Hospitals and diagnostic laboratories
# Research & consulting firms
# Distributors of liquid handling products
# Contract manufacturers of protein liquid handling systems and consumables
# Research institutes and clinical research organizations (CROs)
# Venture capitalists
# Government associations
Download FREE PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=192124302
Research Methodology Followed for This Study:
Top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent submarkets. The overall liquid handling systems industry size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation—by type, product, application, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
Various secondary sources such as World Health Organization, National Center for Biotechnology Information, United Nations Department of Economic and Social Affairs, GLOBOCAN, Centre for Genomic Regulation, International Diabetes Federation, National Institutes of Health, National Institute of Environmental Health Sciences, Eurostat, Food and Drug Administration, corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations have been used to identify and collect information useful for this extensive commercial study of the liquid handling systems market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the liquid handling systems market.
North America expected to account for the major share of the market in 2017
Based on region, the liquid handling systems market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the liquid handling systems market in 2017 on account of growth in the biotechnology and pharmaceutical industries, rising prevalence of chronic diseases, and higher investments in genomics and proteomics research in the region.
Global Leaders:
Key players in the liquid handling systems market include Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eppendorf AG (Germany), Tecan Group Ltd. (Switzerland), Gardner Denver Medical (Germany), Mettler-Toledo International Inc. (U.S.), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), Sartorius AG (Germany), Corning Incorporated (U.S.), Gilson, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Qiagen N.V. (Germany), Lonza Group Ltd (Switzerland), Brooks Automation, Inc. (U.S.), Integra Holding AG (Switzerland), Endress+Hauser AG (Switzerland), Labcyte Inc. (U.S.), BioTek Instruments, Inc. (U.S.), TTP Labtech Ltd (U.K.), Metrohm AG (Switzerland), BRAND GMBH + CO KG (Germany), Tomtec, Inc. (U.S.), Hudson Robotics, Inc. (U.S.), and Orochem Technologies Inc. (U.S.).
Request for FREE Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=192124302
Growth Strategies Followed by Key Players:
The key strategy followed by most companies in the liquid handling systems market are product launches. This strategy accounted for the largest share of the overall growth strategies mapped from 2015 to 2017.
Dental Lab Market - Increasing Popularity of CAD/CAM Technology to Boost the Global Revenue
Research Methodology Followed for This Study:
Top-down and bottom-up approaches were used to validate the size of the global dental laboratory market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research.
Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Some of the secondary resources we referred to are the Canadian Dental Association, American Dental Association, British Dental Association, World Health Organization, Indian Dental Association, and Japan Dental Association.
Download FREE PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223694318
Target Audience:
# Dental product manufacturers & distributors
# Dental equipment manufacturers & distributors
# Dental laboratories
# Government associations and dental practitioners
# Market research and consulting firms
# Venture capitalists and investors
Projected Growth in Revenue in Near Future:
The Dental Laboratory Market is expected to reach USD 43.08 Billion by 2022 from an estimated USD 32.56 Billion in 2017, at a CAGR of 5.8% during the forecast period.
Major Growth Boosting Factors:
The rapid growth in the geriatric population and the associated increase in the prevalence of edentulism, growing dental tourism in emerging markets, rising incidence of dental caries and other periodontal diseases, and the increased outsourcing of certain manufacturing functions to dental laboratories.
Geographical Growth Scenario:
Geographically, the global dental lab market is segmented into North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. Europe holds the largest share of this market. However, the APAC region is expected to witness the highest CAGR during the forecast period of 2017 to 2022. The growth of this segment can be attributed to the rising geriatric population, growing dental tourism, increase in the number of dental laboratories, and increasing outsourcing of various manufacturing services to the region are driving the growth of dental laboratories in APAC. However, the high cost of the dental equipment and materials is expected to hinder the growth of this market to a certain extent.
Request for FREE Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=223694318
Global Key Players:
The global Dental Laboratory Market is characterized by a large number of players. The prominent players in dental lab market are DENTSPLY SIRONA Inc. (U.S.), Danaher Corporation (U.S.), 3M Company (U.S.), Ivoclar Vivadent AG (Liechtenstein), GC Corporation (Japan), Planmeca Group (Finland), VITA Zahnfabrik H. Rauter GmbH & Co. KG (Germany), Shofu Inc. (Japan), BEGO GmbH & Co. KG (Germany), VOCO GmbH (Germany), Ultradent Products, Inc. (U.S.), Septodont Holding (France), Planmeca Oy (Finland), and Kuraray Noritake Dental Inc. (Japan).
Different Growth Strategies Adopted by Key Players:
These companies are pursuing several organic and inorganic growth strategies such as mergers, acquisitions, partnerships, agreements, expansions, and product launches to maintain their position in the dental lab market.
Thursday, March 18, 2021
Protein Assays Market - Emerging Trends & Global Future Forecasts
What Does This Report Provides:
This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the protein assays market, along with revenue estimates & forecasts and market share analysis.
Expected Revenue Growth:
The global protein assays market is expected to reach USD 2.41 Billion by 2022 from USD 1.42 Billion in 2017, at a CAGR of 11.1% from 2017 to 2022. The increasing pharmaceutical & biotech R&D expenditure and favorable government funding scenario for proteomics research are the major factors driving the growth of this market. In this report, the global protein assays market is segmented based on type, product, technology, application, end user, and region.
Download FREE PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93720547
Global Industry Segmentation:
Based on type, the protein assays market is segmented into dye-binding assays, copper-ion-based assays, test strip-based assays, and other protein assays. On the basis of product, the protein assays market is segmented into reagents, kits, and instruments & accessories. In 2017, the reagents segment is expected to account for the largest share of the market. This growth can be attributed to the quick and ready-to-use modifications and the requirement of repeat purchase of reagents.
On the basis of technology, the protein assays market is segmented into absorbance-based protein assays, colorimetric protein assays, and fluorescence-based protein assays. Based on application, the protein assays market is segmented into disease diagnosis, drug discovery & development, and other applications. The drug discovery & development segment is expected to account for the largest market share in 2017. The increase in the R&D expenditure in the life science industry is a key market driver for this segment.
End Users:
Based on end user, the protein assays market is segmented into pharmaceutical & biotechnology companies, clinical laboratories, hospitals, academic research institutes, and other end users. In 2017, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. This growth can be attributed to the increasing drug development in the life science industry.
Geographical Growth Scenario:
On the basis of region, the global protein assays market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The growth in this region is primarily driven by the increasing pharmaceutical and biotechnology R&D expenditure and availability of government funding for life sciences research.
Request FREE Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=93720547
Global Key Players:
Some of the major players operating in the protein assays market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
Global Healthcare IT Industry Expected to Grow Worth $390.7 billion by 2024
Overview of This Study:
This study involved four major activities in estimating the current size of the healthcare IT market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the sizes of segments and subsegments.
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the healthcare IT market. These methods were also used to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and markets have been identified through extensive secondary research.
# The industry’s market size, in terms of value, has been determined through primary and secondary research.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Download FREE PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252
Expected Revenue Surge:
The healthcare IT market is projected to reach USD 390.7 billion by 2024 from USD 187.6 billion in 2019, at a CAGR of 15.8% during the forecast period. The growing volume of patient data, an increase in technological know-how, and demand for quick and efficient healthcare processes and systems are driving the demand for HCIT solutions.
Recent Developments in the Global Healthcare IT Industry:
# In 2019, Philips launched Cares Aging & Caregiving service.
# In 2018, Change Healthcare launched Dx Gap Advisor
# In 2017, Optum acquired DaVita Medical Group (US). The acquisition of DaVita enhanced Optum’s physician-led primary, specialty, in-home, and surgery-care delivery services business.
# In 2017, Cognizant acquired TMG Health (US) to expand its business process-as-a-service solutions for government and public health programs
# In 2018, Optum collaborated with Humana (US), MultiPlan (US) and Quest Diagnostics (US) to form a group to explore the blockchain technology to improve data quality and reduce administrative costs in healthcare
“North America dominated the Healthcare IT market in 2018”
The Healthcare IT market is broadly segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Healthcare IT market in 2018. The large share of this region can be attributed to the technological competencies of healthcare industry and presence of well-established healthcare IT infrastructure in this regions. Changing regulatory requirements for improving quality of healthcare and increasing patient safety and rising healthcare expenditures are some of the key factors driving the growth of the healthcare IT market in North America.
Key Questions Addressed in the Report
# Who are the top 10 players operating in the healthcare IT market?
# What are the driving factors, restraints, opportunities, and challenges in the market?
# What are the industry trends as well as the current scenario in the healthcare IT market?
# What are the growth trends in the market at the segmental and overall market levels?
Request for FREE Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=252
Global Industry Leaders:
Some of the major players operating in this market include Optum (US), Cerner (US), Cognizant (US), Change Healthcare (US), Philips Healthcare (Netherlands), Epic Systems (US), Dell Technologies (US), Allscripts (US), GE Healthcare (US), IBM (US), Athenahealth (US), Oracle Corporation (US), COnduent (US), Infor (US), Tata Consultancy Services (India), Wipro Limited (India), Conifer Health (US), Nuance (US), 3M (US), Inovalon (US), InterSystems (US), Leidos (US), Softheon (US), Omnicell (US), and Ciox Health (US).
This study involved four major activities in estimating the current size of the healthcare IT market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the sizes of segments and subsegments.
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the healthcare IT market. These methods were also used to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and markets have been identified through extensive secondary research.
# The industry’s market size, in terms of value, has been determined through primary and secondary research.
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Download FREE PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252
Expected Revenue Surge:
The healthcare IT market is projected to reach USD 390.7 billion by 2024 from USD 187.6 billion in 2019, at a CAGR of 15.8% during the forecast period. The growing volume of patient data, an increase in technological know-how, and demand for quick and efficient healthcare processes and systems are driving the demand for HCIT solutions.
Recent Developments in the Global Healthcare IT Industry:
# In 2019, Philips launched Cares Aging & Caregiving service.
# In 2018, Change Healthcare launched Dx Gap Advisor
# In 2017, Optum acquired DaVita Medical Group (US). The acquisition of DaVita enhanced Optum’s physician-led primary, specialty, in-home, and surgery-care delivery services business.
# In 2017, Cognizant acquired TMG Health (US) to expand its business process-as-a-service solutions for government and public health programs
# In 2018, Optum collaborated with Humana (US), MultiPlan (US) and Quest Diagnostics (US) to form a group to explore the blockchain technology to improve data quality and reduce administrative costs in healthcare
“North America dominated the Healthcare IT market in 2018”
The Healthcare IT market is broadly segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the Healthcare IT market in 2018. The large share of this region can be attributed to the technological competencies of healthcare industry and presence of well-established healthcare IT infrastructure in this regions. Changing regulatory requirements for improving quality of healthcare and increasing patient safety and rising healthcare expenditures are some of the key factors driving the growth of the healthcare IT market in North America.
Key Questions Addressed in the Report
# Who are the top 10 players operating in the healthcare IT market?
# What are the driving factors, restraints, opportunities, and challenges in the market?
# What are the industry trends as well as the current scenario in the healthcare IT market?
# What are the growth trends in the market at the segmental and overall market levels?
Request for FREE Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=252
Global Industry Leaders:
Some of the major players operating in this market include Optum (US), Cerner (US), Cognizant (US), Change Healthcare (US), Philips Healthcare (Netherlands), Epic Systems (US), Dell Technologies (US), Allscripts (US), GE Healthcare (US), IBM (US), Athenahealth (US), Oracle Corporation (US), COnduent (US), Infor (US), Tata Consultancy Services (India), Wipro Limited (India), Conifer Health (US), Nuance (US), 3M (US), Inovalon (US), InterSystems (US), Leidos (US), Softheon (US), Omnicell (US), and Ciox Health (US).
Wednesday, March 17, 2021
Tracheostomy Products Market is Expecting Major Revenue Surge in Near Future
Growth Influencing Factors:
The major factors driving the growth of the tracheostomy products market are the availability of clinical evidence for their safety & efficacy and increasing adoption of tracheostomy procedures among medical professionals owing to procedural benefits offered by tracheostomy products. Moreover, the rising demand for home care services is expected to play a significant role in fueling market growth.
Expected Revenue Growth:
The tracheostomy products market size is projected to reach USD 220 million by 2024 from USD 179 million in 2019, at a CAGR of 4.2% during the forecast period.
Tracheostomy tubes segment accounted for the largest share of the tracheostomy products market, by type, in 2018
The tracheostomy tubes segment held the largest share of the tracheostomy products industry in 2018. The large share of this segment can be attributed to the procedural and technical benefits offered, such as the ability to pass suctioning catheters or fiberoptic devices into the collapsed area, rapid placement, fast lung isolation, and non-requirement for bronchoscopy in placement.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=79626751
Ciaglia blue rhino tracheostomy segment to register the highest growth in the tracheostomy products market, by technique, during the forecast period
The ciaglia blue rhino tracheostomy segment is expected to grow at the highest CAGR during the forecast period. Growth in this market can primarily be attributed to procedural benefits offered, such as the low risk of damage to the membranous tracheal wall and rapid insertion (owing to the passage of a single dilator). Furthermore, the market growth is driven by favorable reimbursement scenario & medical insurance coverage and the availability of clinical evidence for their safety & efficacy.
Hospitals & surgical centers segment accounted for the largest share of the tracheostomy products market, by the end-user, in 2018
Hospitals & surgical centers were the largest application segment of the tracheostomy products industry, and this trend is expected to continue during the forecast period. A large number of private enterprises are taking steps to cater to the needs of modern, which has resulted in the large share of this segment. Other significant factors include well-equipped state-run healthcare facilities in these regions and growing healthcare consolidation to improve access to healthcare services.
North America dominates the tracheostomy products market
The market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the market in 2018. Factors such as the presence of a highly developed healthcare system, an increasing number of emergency department visits, high adoption of innovative tracheostomy devices among medical professionals, and wide availability of advanced tracheostomy devices are driving the market for tracheostomy products in North America.
Key Players:
The major players operating in the tracheostomy products market are Medtronic plc (Ireland), Smiths Group plc (UK), TRACOE Medical GmbH (Germany), Teleflex Incorporated (US), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other prominent players operating in this market include ConvaTec Group (US), Cook Group (US), Troge Medical GmbH (Germany), Well Lead Medical Co., Ltd. (US), Fuji Systems Corporation (Japan), Andreas Fahl Medizintechnik-Vertrieb GmbH (Germany), Xinxiang Huaxi Sanitary Materials Co., Ltd. (China), Medis Medical (Tianjin) Co. Ltd. (China), Boston Medical (US), and Pulmodyne (US).
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=79626751
The analysis of market developments between 2015 and 2019 revealed that several growth strategies such as collaborations and market expansions were adopted by players to strengthen their product portfolio and maintain a competitive position in the tracheostomy products market.
Ongoing Technological Advancements in the Global Patient Blood Management Industry
Overview of This Research:
The study involved four major activities to estimate the current size of the patient blood management market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of the segments and subsegments.
Key Questions Addressed by the Report:
# What are the growth opportunities related to the adoption of patient blood management solutions across the globe in the future?
# Which product segment will register the highest adoption rate during the forecast period?
# Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
# Emerging countries have immense opportunities for the growth of the market. Will this scenario continue in the next five years?
# Which end users are estimated to adopt patient blood management systems?
# What are the key strategies adopted by the key players operating in the market?
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131352979
Market Size Estimation:
A detailed market estimation approach was followed to estimate and validate the size of the patient blood management market and other dependent submarkets, as mentioned above. The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. The research methodology includes the study of the annual and quarterly financial reports of the top market players as well as interviews with industry experts for key insights (both quantitative and qualitative trends) on the market.
All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources. All the possible parameters that affect the market segments covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Expected Growth in Revenue:
The patient blood management market is projected to reach USD 15.3 billion by 2024 from USD 10.7 billion in 2019, at a CAGR of 7.4% from 2019 to 2024.
Growth Boosting Factors:
The rising prevalence of blood disorders and the increasing number of blood donations & blood donors will fuel market growth over the forecast period. Moreover, the rising prevalence of target diseases and technological advancements in the patient blood management industry will further fuel the growth of the market in the near future.
Blood banks were the key end users in the patient blood management market in 2019
On the basis of end users, the patient blood management market is segmented into hospitals and blood banks. The increasing number of blood donations has increased the need for proper management of blood. Blood banks are the key end users for various blood processing devices, blood collection devices, and blood storage devices. The key factors attributing to the growth of the blood banks segment include the growing awareness about blood donations, rising automation in blood banks, and the increase in the number of blood banks in developing countries.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=131352979
Geographical Growth Scenario:
The Asia Pacific region is expected to register significant growth during the forecast period of 2019-2024
The patient blood management market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific blood management market is expected to register significant growth over the forecast period due to the modernization of healthcare infrastructure, increasing prevalence of chronic lifestyle diseases, and rising awareness about blood donation & blood safety. China accounted for a major share of the Asia Pacific market, owing to a large patient pool and favorable government guidelines to improve healthcare infrastructure in the country.
Global Leaders:
The prominent players in the patient blood management market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc.(Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.
Different Growth Strategies Adopted by Them:
An analysis of market developments between 2016 and 2019 revealed that several growth strategies such as product launches and enhancements, collaborations, partnerships, agreements, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the patient blood management market.
Read the Detailed Article@
https://www.marketsandmarkets.com/Market-Reports/patient-blood-management-market-131352979.html
Subscribe to:
Posts (Atom)